| Timing of initiation of antiretroviral drugs during tuberculosis therapy SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ... New England Journal of Medicine 362 (8), 697-706, 2010 | 925 | 2010 |
| Timing of antiretroviral therapy for HIV-1 infection and tuberculosis DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ... New England Journal of Medicine 365 (16), 1482-1491, 2011 | 737 | 2011 |
| The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ... The lancet Respiratory medicine 5 (4), 291-360, 2017 | 726 | 2017 |
| Integration of antiretroviral therapy with tuberculosis treatment SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ... New England Journal of Medicine 365 (16), 1492-1501, 2011 | 650 | 2011 |
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 549 | 2018 |
| Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care N Dookie, S Rambaran, N Padayatchi, S Mahomed, K Naidoo Journal of Antimicrobial Chemotherapy 73 (5), 1138-1151, 2018 | 346 | 2018 |
| Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis SE Dorman, JL Johnson, S Goldberg, G Muzanye, N Padayatchi, ... American journal of respiratory and critical care medicine 180 (3), 273-280, 2009 | 339 | 2009 |
| Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates … KA Cohen, T Abeel, A Manson McGuire, CA Desjardins, V Munsamy, ... PLoS medicine 12 (9), e1001880, 2015 | 308 | 2015 |
| XDR-TB in South Africa: no time for denial or complacency JA Singh, R Upshur, N Padayatchi PLoS medicine 4 (1), e50, 2007 | 287 | 2007 |
| High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers MR O'Donnell, J Jarand, M Loveday, N Padayatchi, J Zelnick, L Werner, ... Annals of internal medicine 153 (8), 516-522, 2010 | 259 | 2010 |
| Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance CA Desjardins, KA Cohen, V Munsamy, T Abeel, K Maharaj, BJ Walker, ... Nature genetics 48 (5), 544-551, 2016 | 195 | 2016 |
| Systematic review of clofazimine for the treatment of drug-resistant tuberculosis M Gopal, N Padayatchi, JZ Metcalfe, MR O'Donnell The International journal of tuberculosis and lung disease 17 (8), 1001-1007, 2013 | 179 | 2013 |
| The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial K Naidoo, N Yende-Zuma, N Padayatchi, K Naidoo, N Jithoo, G Nair, ... Annals of internal medicine 157 (5), 313-324, 2012 | 152 | 2012 |
| Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis EP Harausz, AJ Garcia-Prats, S Law, HS Schaaf, T Kredo, JA Seddon, ... PLoS medicine 15 (7), e1002591, 2018 | 149 | 2018 |
| High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000–2003 JCM Brust, NR Gandhi, H Carrara, G Osburn, N Padayatchi The international journal of tuberculosis and lung disease 14 (4), 413-419, 2010 | 147 | 2010 |
| Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection MR O’Donnell, N Padayatchi, C Kvasnovsky, L Werner, I Master, ... Emerging infectious diseases 19 (3), 416, 2013 | 143 | 2013 |
| The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis FA Sirgel, PB Fourie, PR Donald, N Padayatchi, R Rustomjee, J Levin, ... American journal of respiratory and critical care medicine 172 (1), 128-135, 2005 | 143 | 2005 |
| Towards host-directed therapies for tuberculosis A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ... Nature reviews Drug discovery 14 (8), 511-512, 2015 | 133 | 2015 |
| Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa M Loveday, K Wallengren, J Brust, J Roberts, A Voce, B Margot, J Ngozo, ... The International Journal of Tuberculosis and Lung Disease 19 (2), 163-171, 2015 | 129 | 2015 |
| HIV testing and disclosure: a qualitative analysis of TB patients in South Africa A Daftary, N Padayatchi, M Padilla AIDS care 19 (4), 572-577, 2007 | 125 | 2007 |
